NWRN fundamentals
An in-depth look to NEWRON PHARMA N operating, investing, and financing activities
NWRN free cash flow for H2 23 is -4.19 M CHF. For 2023, NWRN free cash flow was -9.86 M CHF and operating cash flow was -9.85 M CHF.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM